Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-24-050828

Options or other derivatives

  • Director acquired 7,688 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Xavier Ramnik · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-06 Grant or award : show line 1 in the form Option to Buy +7,688 7,688 D
Loading xslF345X05/ownership.xml…